Related Experiment Video
Updated: Oct 5, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Changes of serum uric acid and its clinical correlation in children with dilated cardiomyopathy
Ting-Ting Li1, Hao-Ying Li1, Ji Cheng1
1Department of Cardiology, Tianjin Children's Hospital/Tianjin University Children's Hospital, Tianjin, China.
Insights
Elevated serum uric acid (UA) levels are present in children with dilated cardiomyopathy (DCM) and correlate with disease severity. Serum UA may serve as a biomarker for pediatric DCM.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Research
- Biomarker Discovery
Background:
- Dilated cardiomyopathy (DCM) is the most common pediatric cardiomyopathy.
- Uric acid (UA) is linked to cardiovascular disease, but its role in pediatric DCM is under-researched.
Purpose of the Study:
- To investigate serum UA levels in children with DCM.
- To analyze the correlation between serum UA and clinical parameters in pediatric DCM.
Main Methods:
- Retrospective analysis of clinical data from 49 children with DCM and 44 healthy controls.
- Measurement of serum UA levels and echocardiographic parameters (LVEDD, LVESD, LAD, LVEF, LVFS).
Main Results:
- Children with DCM had significantly higher serum UA, LVEDD, LVESD, and LAD, and lower LVEF and LVFS compared to controls.
- Elevated serum UA correlated with higher NYHA functional class and poorer echocardiographic measures.
- Significant statistical differences (P<0.01) were observed between groups and within DCM severity classes.
Conclusions:
- Elevated serum UA levels are found in children with DCM.
- Serum UA levels correlate with disease severity, including NYHA class and echocardiographic findings.
- Serum UA may function as a valuable biomarker for assessing DCM severity in pediatric patients.
Background:
Dilated cardiomyopathy (DCM) is the most common type of childhood cardiomyopathy and uric acid (UA) is considered closely associated with cardiovascular disease. There are few reports about the relationship between serum UA level and DCM in children, and the present study aimed to analyze the changes and clinical correlation of the two.
Methods:
The clinical data of 49 children under 16 years old and who were hospitalized with DCM, and 44 healthy children who underwent physical examination in the same period at Tianjin Children's Hospital from June 2015 to November 2019 were analyzed retrospectively.
Results:
The 49 children in the case group included 17 males and 32 females, aged from 2 to 172 months. The case group were divided into New York Heart Association (NYHA) functional class I (n=2), class II (n=17), class III (n=11), and class IV (n=19). The 44 healthy children selected as the control group included 20 males and 24 females aged from 2 to 161 months. The serum UA level was detected, and an ultrasonic cardiogram was conducted in each child. The serum UA level, left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter (LVESD), and left atrial diameter (LAD) of the case group were higher than that of the control group, while the left ventricular ejection fraction (LVEF) and left ventricular fractional shortening (LVFS) were lower than that of the control group, and significant statistical differences were seen between the two groups (P<0.01). The serum UA level, LVEDD, LVESD, and LAD of NYHAIII-IV class patients were higher than that of the NYHAI-II class, but LVEF and LVFS were lower than that of the NYHA I-II class, and there were significant statistical differences between the two groups (P<0.01). Statistical correlations were seen between the serum UA level and NYHA functional class, LVEDD, LVESD, LAD, LVEF, and LVFS (rs=0.599, 0.567, 0.579, 0.475, -0.333, -0.341, respectively, P<0.05).
Conclusions:
Elevated serum UA levels exist in children with DCM and correlate with NYHA functional class and ultrasonic values. Change in serum UA levels may be used as a biomarker reflecting the severity of DCM in children.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy II: Dilated Cardiomyopathy
Serum Studies: Renal Function Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
![Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F61682.jpg&w=3840&q=50)
